Download RTF

Publications for Glen Reid
Publications for Glen Reid
2016
Kao, S., Kirschner, M., Cooper, W., Tran, T.,
Burgers, S., Wright, C., Korse, T., van den
Broek, D., Edelman, J., Vallely, M., McCaughan,
B., Pavlakis, N., Clarke, S., van Zandwijk, N.,
Reid, G., et al (2016). A proteomics-based
approach identifies secreted protein acidic and
rich in cysteine as a prognostic biomarker in
malignant pleural mesothelioma. British Journal
of Cancer, 114(5), 524-531. <a
href="http://dx.doi.org/10.1038/bjc.2015.470">[
More Information]</a>
Hoda, M., Dong, Y., Rozsas, A., Klikovits, T.,
Laszlo, V., Ghanim, B., Stockhammer, P.,
Ozsvar, J., Jakopovic, M., Reid, G., van
Zandwijk, N., et al (2016). Circulating activin A
is a novel prognostic biomarker in malignant
pleural mesothelioma - A multi-institutional
study. European Journal of Cancer, 63, 64-73.
<a
href="http://dx.doi.org/10.1016/j.ejca.2016.04.01
8">[More Information]</a>
Reid, G., Kao, S., Pavlakis, N., Brahmbhatt, H.,
MacDiarmid, J., Clarke, S., Boyer, M., van
Zandwijk, N. (2016). Clinical development of
TargomiRs, a miRNA mimic-based treatment for
patients with recurrent thoracic cancer.
Epigenomics, 8(8), 1079-1085. <a
href="http://dx.doi.org/10.2217/epi-2016-0035">
[More Information]</a>
Cheng, V., Wright, C., Kirschner, M., Williams,
M., Sarun, K., Sytnyk, V., Leshchynska, I.,
Edelman, J., Vallely, M., McCaughan, B., van
Zandwijk, N., Reid, G., et al (2016). KCa1.1, a
calcium-activated potassium channel subunit
alpha 1, is targeted by miR-17-5p and modulates
cell migration in malignant pleural
mesothelioma. Molecular Cancer, 15(1), 1-12.
<a
href="http://dx.doi.org/10.1186/s12943-016-052
9-z">[More Information]</a>
Lin, R., Kirschner, M., Cheng, V., van Zandwijk,
N., Reid, G. (2016). MicroRNA gene expression
signatures in long-surviving malignant pleural
mesothelioma patients. Genomics Data, 9, 44-49.
<a
href="http://dx.doi.org/10.1016/j.gdata.2016.06.0
09">[More Information]</a>
van Zandwijk, N., Soeberg, M., Reid, G. (2016).
Using a multidisciplinary approach to combat the
burden of asbestos-related disease. Medical
Journal of Australia, 204(2), 52-52.e1. <a
href="http://dx.doi.org/10.5694/mja15.01209">[
More Information]</a>
2015
Kao, S., Fulham, M., Wong, K., Cooper, W.,
Brahmbhatt, H., MacDiarmid, J., Pattison, S.,
Sagong, J., Huynh, Y., Leslie, F., Pavlakis, N.,
Clarke, S., Boyer, M., Reid, G., van Zandwijk,
N. (2015). A significant metabolic and
radiological response after a novel targeted
microRNA-based treatment approach in
malignant pleural mesothelioma. American
Journal of Respiratory and Critical Care
Medicine, 191(12), 1467-1469. <a
href="http://dx.doi.org/10.1164/rccm.201503-04
61LE">[More Information]</a>
Klebe, S., Griggs, K., Cheng, Y., Driml, J.,
Henderson, D., Reid, G. (2015). Blockade of
aquaporin 1 inhibits proliferation, motility, and
metastatic potential of mesothelioma in vitro but
not in an in vivo model. Disease Markers, 2015,
1-9. <a
href="http://dx.doi.org/10.1155/2015/286719">[
More Information]</a>
Kirschner, M., Emily, P., Hoda, M., Rozsas, A.,
Griggs, K., Cheng, Y., Edelman, J., Kao, S.,
Hyland, R., Dong, Y., Vallely, M., van
Zandwijk, N., Reid, G., et al (2015). Fibulin-3
levels in malignant pleural mesothelioma are
associated with prognosis but not diagnosis.
British Journal of Cancer, 113(6), 963-969. <a
href="http://dx.doi.org/10.1038/bjc.2015.286">[
More Information]</a>
Birnie, K., Yip, Y., Ng, D., Kirschner, M., Reid,
G., Prele, C., Musk, A., Lee, Y., Thompson, P.,
Mutsaers, S., et al (2015). Loss of mir-223 and
JNK Signalling Contribute to Elevated Stathmin
in Malignant Pleural Mesothelioma. Molecular
Cancer Research, 13(7), 1106-1118. <a
href="http://dx.doi.org/10.1158/1541-7786.MCR
-14-0442">[More Information]</a>
Lin, R., van Zandwijk, N., Reid, G. (2015).
MicroRNA Therapeutics � Back in Vogue?
Journal of Investigative Genomics, 2(1), 12.
Glover, A., Zhao, J., Gill, A., Weiss, J.,
Mugridge, N., Kim, E., Feeney, A., Ip, J., Reid,
G., Clarke, S., Robinson, B., Sidhu, S., et al
(2015). microRNA-7 as a tumor suppressor and
novel therapeutic for adrenocortical carcinoma.
Oncotarget, 6(34), 36675-36688. <a
href="http://dx.doi.org/10.18632/oncotarget.538
3">[More Information]</a>
Maher, S., Bibby, B., Moody, H., Reid, G.
(2015). MicroRNAs and Cancer. In Steven G.
Gray (Eds.), Epigenetic Cancer Therapy, (pp.
67-90). London: Academic Press. <a
href="http://dx.doi.org/10.1016/B978-0-12-8002
06-3.00004-5">[More Information]</a>
Reid, G. (2015). MicroRNAs in mesothelioma:
From tumour suppressors and biomarkers to
therapeutic targets. Journal of Thoracic Disease,
7(6), 1031-1040. <a
Publications for Glen Reid
href="http://dx.doi.org/10.3978/j.issn.2072-1439.
2015.04.56">[More Information]</a>
Williams, M., Kirschner, M., Cheng, Y., Hanh,
J., Weiss, J., Amaro-Mugridge, N., Wright, C.,
Linton, A., Kao, S., Edelman, J., Vallely, M.,
Cooper, W., van Zandwijk, N., Reid, G., et al
(2015). miR-193a-3p is a potential tumor
suppressor in malignant pleural mesothelioma.
Oncotarget, 6(27), 23480-23495. <a
href="http://dx.doi.org/10.18632/oncotarget.434
6">[More Information]</a>
Kirschner, M., Cheng, Y., Armstrong, N., Lin,
R., Kao, S., Linton, A., Klebe, S., McCaughan,
B., van Zandwijk, N., Reid, G. (2015).
MiR-Score: A novel 6-microRNA signature that
predicts survival outcomes in patients with
malignant pleural mesothelioma. Molecular
Oncology, 9(3), 715-726. <a
href="http://dx.doi.org/10.1016/j.molonc.2014.1
1.007">[More Information]</a>
2014
Linton, A., Cheng, Y., Griggs, K., Kirschner, M.,
Gattani, S., Srikaran, S., Kao, S., McCaughan,
B., Klebe, S., van Zandwijk, N., Reid, G. (2014).
An RNAi-based screen reveals PLK1, CDK1 and
NDC80 as potential therapeutic targets in
malignant pleural mesothelioma. British Journal
of Cancer, 110(2), 510-519. <a
href="http://dx.doi.org/10.1038/bjc.2013.731">[
More Information]</a>
Cheng, N., van Zandwijk, N., Reid, G. (2014).
Cilengitide Inhibits Attachment and Invasion of
Malignant Pleural Mesothelioma Cells through
Antagonism of Integrins αvβ3 and αvβ5. PloS
One, 9(3), 1-10. <a
href="http://dx.doi.org/10.1371/journal.pone.009
0374">[More Information]</a>
2013
Kirschner, M., van Zandwijk, N., Reid, G.
(2013). Cell-free microRNAs: potential
biomarkers in need of standardized reporting.
Frontiers in Genetics, 4, 1-5. <a
href="http://dx.doi.org/10.3389/fgene.2013.0005
6">[More Information]</a>
Henderson, D., Reid, G., Kao, S., Van Zandwijk,
N., Klebe, S. (2013). Challenges and
controversies in the diagnosis of malignant
mesothelioma: Part 2. Malignant mesothelioma
subtypes, pleural synovial sarcoma, molecular
and prognostic aspects of mesothelioma, BAP1,
aquaporin-1 and microRNA. Journal of Clinical
Pathology, 66(10), 854-861. <a
href="http://dx.doi.org/10.1136/jclinpath-2013-2
01609">[More Information]</a>
Henderson, D., Reid, G., Kao, S., Van Zandwijk,
N., Klebe, S. (2013). Challenges and
controversies in the diagnosis of mesothelioma:
Part 1. Cytology-only diagnosis, biopsies,
immunohistochemistry, discrimination between
mesothelioma and reactive mesothelial
hyperplasia, and biomarkers. Journal of Clinical
Pathology, 66(10), 847-853. <a
href="http://dx.doi.org/10.1136/jclinpath-2012-2
01303">[More Information]</a>
Wright, C., Kirschner, M., Cheng, Y., O’Byrne,
K., Gray, S., Schelch, K., Hoda, M., Klebe, S.,
McCaughan, B., van Zandwijk, N., Reid, G.
(2013). Long Non Coding RNAs (lncRNAs) Are
Dysregulated in Malignant Pleural Mesothelioma
(MPM). PloS One, 8(8), 1-12. <a
href="http://dx.doi.org/10.1371/journal.pone.007
0940">[More Information]</a>
Lim, C., Prele, C., Cheah, H., Cheng, Y., Klebe,
S., Reid, G., Watkins, D., Baltic, S., Thompson,
P., Mutsaers, S. (2013). Mutational Analysis of
Hedgehog Signaling Pathway Genes in Human
Malignant Mesothelioma. PloS One, 8(6), 1-12.
<a
href="http://dx.doi.org/10.1371/journal.pone.006
6685">[More Information]</a>
Reid, G., Pel, M., Kirschner, M., Cheng, Y.,
Amaro-Mugridge, N., Madrid-Weiss, J.,
Williams, M., Wright, C., Edelman, J., Vallely,
M., van Zandwijk, N., et al (2013). Restoring
expression of miR-16: a novel approach to
therapy for malignant pleural mesothelioma.
Annals of Oncology, 24(12), 3128-3135. <a
href="http://dx.doi.org/10.1093/annonc/mdt412"
>[More Information]</a>
Kirschner, M., Edelman, J., Kao, S., Vallely, M.,
van Zandwijk, N., Reid, G. (2013). The Impact
of Hemolysis on Cell-Free microRNA
Biomarkers. Frontiers in Genetics, 4, 1-13. <a
href="http://dx.doi.org/10.3389/fgene.2013.0009
4">[More Information]</a>
Cheng, Y., Kirschner, M., Cheng, N., Gattani, S.,
Klebe, S., Edelman, J., Vallely, M., McCaughan,
B., Jin, H., van Zandwijk, N., Reid, G. (2013).
ZIC1 Is Silenced and Has Tumor Suppressor
Function in Malignant Pleural Mesothelioma.
Journal of Thoracic Oncology, 8(10),
1317-1328. <a
href="http://dx.doi.org/10.1097/JTO.0b013e3182
a0840a">[More Information]</a>
2012
Kirschner, M., Cheng, V., Badrian, B., Kao, S.,
Creaney, J., Edelman, J., Armstrong, N., Vallely,
M., Musk, A., Robinson, B., McCaughan, B.,
van Zandwijk, N., Reid, G., et al (2012).
Increased Circulating miR-625-3p: A Potential
Biomarker for Patients With Malignant Pleural
Mesothelioma. Journal of Thoracic Oncology,
7(7), 1184-1191. <a
href="http://dx.doi.org/10.1097/JTO.0b013e3182
572e83">[More Information]</a>
Publications for Glen Reid
Linton, A., van Zandwijk, N., Reid, G., Clarke,
S., Cao, C., Kao, S. (2012). Inflammation in
malignant mesothelioma - friend or foe? Annals
of Cardiothoracic Surgery, 1(4), 516-522. <a
href="http://dx.doi.org/10.3978/j.issn.2225-319X
.2012.10.02">[More Information]</a>
van Zandwijk, N., Reid, G., Linton, A., Kao, S.
(2012). Radical surgery for malignant pleural
mesothelioma: have we identified the appropriate
selection tools? Annals of Cardiothoracic
Surgery, 1(4), 481-486. <a
href="http://dx.doi.org/10.3978/j.issn.2225-319X
.2012.10.01">[More Information]</a>
Research Notes, 4(Article 148), 1-7. <a
href="http://dx.doi.org/10.1186/1756-0500-4-14
8">[More Information]</a>
Kao, S., Lee, K., Armstrong, N., Clarke, S.,
Vardy, J., van Zandwijk, N., Reid, G., Burn, J.,
McCaughan, B., Henderson, D., et al (2011).
Validation of tissue microarray technology in
malignant pleural mesothelioma. Pathology,
43(2), 128-132. <a
href="http://dx.doi.org/10.1097/PAT.0b013e328
342016c">[More Information]</a>
2010
Lasham, A., Samuel, W., Cao, H., Patel, R.,
Mehta, R., Stern, J., Reid, G., Woolley, A.,
Miller, L., Black, M., Braithwaite, A., et al
(2012). YB-1, the E2F Pathway, and Regulation
of Tumor Cell Growth. Journal of the National
Cancer Institute, 104(2), 133-46. <a
href="http://dx.doi.org/10.1093/jnci/djr512">[M
ore Information]</a>
Lasham, A., Herbert, M., Coppieters 't Wallant,
N., Patel, R., Feng, S., Eszes, M., Cao, H., Reid,
G. (2010). A rapid and sensitive method to detect
siRNA-mediated mRNA cleavage in vivo using
5' RACE and a molecular beacon probe. Nucleic
Acids Research, 38(3), e19 - 1-e19 - 11. <a
href="http://dx.doi.org/10.1093/nar/gkp1076">[
More Information]</a>
2011
Li, Y., Revalde, J., Reid, G., Paxton, J. (2010).
Interactions of dietary phytochemicals with ABC
transporters: possible implications for drug
disposition and multidrug resistance in cancer.
Drug Metabolism Reviews, 42(4), 590-611. <a
href="http://dx.doi.org/10.3109/0360253100375
8690">[More Information]</a>
Reid, G., Kirschner, M., van Zandwijk, N.
(2011). Circulating microRNAs: Association
with disease and potential use as biomarkers.
Critical Reviews in Oncology / Hematology,
80(2), 193-208. <a
href="http://dx.doi.org/10.1016/j.critrevonc.2010
.11.004">[More Information]</a>
Kirschner, M., Kao, S., Edelman, J., Armstrong,
N., Vallely, M., van Zandwijk, N., Reid, G.
(2011). Haemolysis during Sample Preparation
Alters microRNA Content of Plasma. PloS One,
6(9), 1-9. <a
href="http://dx.doi.org/10.1371/journal.pone.002
4145">[More Information]</a>
Kao, S., Klebe, S., Henderson, D., Reid, G.,
Chatfield, M., Armstrong, N., Yan, T., Vardy, J.,
Clarke, S., van Zandwijk, N., McCaughan, B.
(2011). Low Calretinin Expression and High
Neutrophil-To-Lymphocyte Ratio Are Poor
Prognostic Factors in Patients with Malignant
Mesothelioma Undergoing Extrapleural
Pneumonectomy. Journal of Thoracic Oncology,
6(11), 1923-1929. <a
href="http://dx.doi.org/10.1097/JTO.0b013e3182
2a3740">[More Information]</a>
Kao, S., Reid, G., van Zandwijk, N., Henderson,
D., Klebe, S. (2011). Molecular biomarkers in
malignant mesothelioma: state of the art.
Pathology, 43(3), 201-212. <a
href="http://dx.doi.org/10.1097/PAT.0b013e328
3445e67">[More Information]</a>
Herbert, M., Coppieters 't Wallant, N., Lasham,
A., Cao, H., Reid, G. (2011). The importance of
RT-qPCR primer design for the detection of
siRNA-mediated mRNA silencing. BMC
Li, Y., Revalde, J., Reid, G., Paxton, J. (2010).
Modulatory effects of curcumin on multi-drug
resistance-associated protein 5 in pancreatic
cancer cells. Cancer Chemotherapy and
Pharmacology. <a
href="http://dx.doi.org/10.1007/s00280-010-151
5-6">[More Information]</a>